Impact of mecA Gene Testing and Intervention by Infectious Disease Clinical Pharmacists on Time to Optimal Antimicrobial Therapy for Staphylococcus aureus Bacteremia at a University Hospital | Zendy

Peggy L. Carver | Zendy; ShuWen Lin | Zendy; Daryl D. DePestel | Zendy; Duane W. Newton | Zendy

Open Access

Impact of mecA Gene Testing and Intervention by Infectious Disease Clinical Pharmacists on Time to Optimal Antimicrobial Therapy for Staphylococcus aureus Bacteremia at a University Hospital

Author(s) -

Peggy L. Carver,

ShuWen Lin,

Daryl D. DePestel,

Duane W. Newton

Publication year - 2008

Publication title -

journal of clinical microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.349

H-Index - 255

eISSN - 1070-633X

pISSN - 0095-1137

DOI - 10.1128/jcm.00801-08

Subject(s) - bacteremia , staphylococcus aureus , antimicrobial , medicine , infectious disease (medical specialty) , staphylococcal infections , disease , microbiology and biotechnology , intensive care medicine , antibiotics , biology , bacteria , genetics

In patients withStaphylococcus aureus bacteremia, intervention by infectious disease clinical pharmacists on the basis of the results of tests formecA resulted in a 25.4-h reduction in the time to optimal antimicrobial therapy, from 64.7 ± 36.8 to 39.3 ± 15.5 h (P = 0.002), which may result in decreased mortality.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research